RESMED INC — Director's Dealing 2016

Oct 18, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2016-10-17

Reporting Person: Hollingshead James (President, Americas)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-10-17	ResMed Common Stock	M	5264	$43.63	Acquired	52744	Direct
2016-10-17	ResMed Common Stock	S	5264	$64.43	Disposed	47480	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-10-17	ResMed Common Stock Options	$43.63	M	5264	Disposed	2020-03-01	ResMed Common Stock (5264)	Direct

Footnotes

F1: The transaction was conducted under a Rule10b5-1 Plan.

F2: Represents date options first became exercisable. Options vest ? per year.